PE GI Solutions and Ambulatory Center for Endoscopy, LLC (ACE) have acquired Hudson Bergen Medical Center, LLC. The surgical center has officially become a second location for the existing Ambulatory Center for Endoscopy, LLC and has formally been renamed Hudson Bergen Endoscopy and Surgical Center, LLC. PE GI Solutions entered into a strategic partnership with ACE in 2012 and has provided support in delivering clinical and operational excellence for the center over the last nine ye

Hospital for Special Surgery (HSS) and the manufacturer, LimaCorporate S.p.A., today unveiled the first provider-based 3D design and printing facility for custom complex joint replacement solutions.  HSS is consistently ranked No. 1 in orthopedics worldwide by Newsweek, and nationally by U.S. News & World Report.  Headquartered in Italy, LimaCorporate is the world leader in 3D design and printing of personalized components for orthopedic patient care. Known as the ProM

Medigate, a healthcare-dedicated device security and asset management company, today announced its partnership with Rapid7. Together, the two firms are dedicated to securing real time health. The joint solution will enable healthcare delivery organizations (HDOs) with never-before-available vulnerability management insights powering new best practices. Each day, healthcare organizations operate on clinical networks with a mix of traditional medical and IoT equipment connecting from

Renovacor, Inc., an early-stage biotechnology company developing AAV-based gene therapies for devastating cardiovascular and central nervous system (CNS) diseases resulting from BAG3 gene dysfunction, and Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) ("CHAQ"), a special purpose acquisition company or SPAC, sponsored by affiliates of Chardan Capital Markets ("Chardan"), announced today they have entered into a definitive business combination agreement. Upon closing of

Leading global executive search and leadership advisory firm WittKieffer and the International Hospital Federation (IHF) today announced a partnership to advance the organization's Young Executive Leaders (YEL) program, helping to build global healthcare leadership competencies among the next generation of leaders in the Federation's international membership. Established in 1929, the International Hospital Federation is a global, not-for-profit, non-governmental membership o

Recovery Force, LLC is pleased to announce the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of the Movement and Compressions (MAC) System, a novel, data-driven, mobility measurement device designed for hospital and home use. What It Is The MAC System provides therapeutic compressions to the lower leg and displays real-time patient mobility data.  The system empowers all bedside caregivers with critical metr

Fusion Robotics LLC, a spinal robotics and navigation company today announced the successful completion of the first spine procedure using the company's technology platform. The procedure, completed by Dr. Kevin Foley at Baptist Memorial Hospital in Memphis TN, was a single-level minimally invasive transforaminal lumbar interbody fusion (MI-TLIF), including the placement of pedicle screw fixation guided by the Fusion Robotics system. "We're thrilled to be the first hosp

Tabula Rasa HealthCare, Inc., a healthcare technology company advancing the safe use of medications, announced that on March 17, TRHC Chair and CEO, Calvin H. Knowlton, PhD, appeared before the New Jersey General Assembly's Human Services Committee to discuss legislation that would create a medication risk reduction model for the State's Medicaid program.  Dr. Knowlton expressed TRHC's full support for the measure. "The medication risk reduction model contempla

BD (Becton, Dickinson and Company), a leading global medical technology company, has expanded a voluntary recall that was initiated on June 23, 2020 for specified catalog numbers of the ChloraPrep™ 3 mL applicator due to possible fungal contamination under certain environmental conditions. BD has  determined that storage of the ChloraPrep™ 3 mL Applicator in regions of the world with high heat and humidity, where product may be continuously exposed to temperatures o

Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, today announced a commercial partnership with Mologic, a leading developer and manufacturer of lateral flow and rapid diagnostic tests. The partnership will work towards CE marking of Aptamer Group’s AptaDx SARS-CoV-2 lateral flow rapid antigen test for professional use, to detect the SARS-CoV-2 spike protein antigen in anterior nasal swabs. Initial test analysis with laboratory samples has demonstrated